NeurAxon's Other Investors

NeurAxon raised a round of funding on , . Investors include Genesys Capital.

NeurAxon is discovering and developing next generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous s…

Articles about NeurAxon's Other Investors: